- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
NanoInk, Inc., an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life science, pharmaceutical, and semiconductor industries, announced today it has been awarded three additional patents pertaining to its core patented Dip Pen Nanolithography® (DPN®) patterning technology for nanoscale manufacturing.
The U.S. Patent and Trademark Office granted patent number 7,098,056, entitled Apparatus, Materials, and Methods for Fabrication and Catalysis. The patented technology involves the use of DPN patterning for immobilizing catalyst materials and related compounds on surfaces. These regimes are shown to be primarily useful for growing uniform polymeric structures such as carbon nanotubes.
In addition, patent number 7,199,305, Protosubstrates describes the design, method of fabrication and compatibility with nanolithography of a prototyping tool. The tool consists primarily of a surface suitable for designing tests of nanoscale materials (most notably electronic) and components for connecting that surface to external, conventional test equipment.
Finally, patent number 7,279,046, Method and Apparatus for Aligning Patterns on a Substrate, describes a method of aligning features created via DPN patterning with extremely high precision. The method, which works for successive DPN patterning steps and integration with other forms of lithography, employs Scanning Probe Microscopy, integrated video capture, and novel software algorithms.
NanoInk's growing patent portfolio is composed of over 120 total documents in 38 families, including both owned and licensed properties. Robert Janosky, NanoInk president and COO, said, "NanoInk continues to invest in its future by developing and patenting powerful and innovative technologies which will enable the commercialization of numerous methods and products as the nanotechnology manufacturing space matures."
Other related intellectual property activity at NanoInk, Inc. includes two reexaminations. Recently, in an ex parte reexamination proceeding initiated by NanoInk, the US Patent & Trademark Office (PTO) cancelled all but three claims of BioForce Nanosciences, Inc.'s patent number 6,573,369. Moreover, the PTO narrowed the scope of the three remaining claims in this ex parte reexamination. Furthermore, the PTO has also granted NanoInk's reexamination request for a counterpart divisional BioForce patent, U.S. Patent No. 6,998,228, and this reexamination remains pending.
Tom Levesque, vice president of NanoInk's Dip Pen Nanolithography Business, stated, "While one may question the PTO's decision to allow three narrow claims, we are nevertheless pleased to see that the PTO substantially reduced the scope of the initial patent. NanoInk will continue to aggressively pursue every means to defend our intellectual property investments."
About NanoInk, Inc.
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life science and semiconductor industries. With DPN®, a patented and proprietary nanofabrication technology that allows for unmatched flexibility and accuracy, and also its high-resolution Nanoencryption™ technology, NanoInk is able to offer its pharmaceutical customers innovative solutions to fight counterfeiting and illegal diversion of blockbuster pharmaceutical products. Other key applications include nanoscale additive repair and nanoscale rapid prototyping. Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 120 issued or pending patents and patent applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, and the University of Illinois at Urbana-Champaign and the Georgia Institute of Technology.
For more information, please click here
Dresner Corporate Services for NanoInk
Dresner Corporate Services for NanoInk
Copyright © Market WireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Chemical trickery corrals 'hyperactive' metal-oxide cluster December 8th, 2016
Leti IEDM 2016 Paper Clarifies Correlation between Endurance, Window Margin and Retention in RRAM for First Time: Paper Presented at IEDM 2016 Offers Ways to Reconcile High-cycling Requirements and Instability at High Temperatures in Resistive RAM December 6th, 2016
Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016
Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016
UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016
Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016
Leti to Tackle Tomorrow's Research Strategies with Stanford University’s SystemX Alliance: French R&D Center Is the First Research Institute to Join the Collaboration and Provides Bridges Between Academia and Industry, Leveraging Alliance’s Potential October 4th, 2016
Picosun patents ALD nanolaminate to prevent electronics from overheating September 28th, 2016
NIST Patents Single-Photon Detector for Potential Encryption and Sensing Apps September 16th, 2016
Iran to hold intl. school on application of nanomaterials in medicine September 20th, 2016
Tailored probes for atomic force microscopes: 3-D laser lithography enhances microscope for studying nanostructures in biology and engineering/ publication in Applied Physics Letters August 11th, 2016